Decheng Capital LLC Q4 2025 Filing
Filed February 12, 2026
Portfolio Value
$743.4B
Holdings
19
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (19 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | CGONCG ONCOLOGY INC | 6,371,669 | $264.6B | 35.59% | |
| 2 | NUVBNuvation Bio Inc. | 25,954,439 | $232.6B | 31.28% | |
| 3 | UPBUpstream Bio Inc. | 3,143,078 | $85.3B | 11.48% | |
| 4 | AARDAARDVARK THERAPEUTICS INC | 3,917,299 | $51.4B | 6.92% | |
| 5 | LYELLyell Immunopharma, Inc. | 692,050 | $21.3B | 2.87% | |
| 6 | NAMSNEWAMSTERDAM PHARMA CO NV | 592,057 | $20.8B | 2.79% | |
| 7 | RVMDREVOLUTION MEDICINES INC(NSM) | 200,000 | $15.9B | 2.14% | |
| 8 | RCUSArcus Biosciences, Inc | 541,559 | $12.9B | 1.74% | |
| 9 | ACRSAclaris Therapeutics, Inc. | 4,041,736 | $12.2B | 1.64% | |
| 10 | EQEquillium Inc. | 4,447,308 | $6.9B | 0.93% | |
| 11 | BYSIBeyondSpring Inc. | 3,800,702 | $6.2B | 0.83% | |
| 12 | CRNXCRINETICS PHARMACEUTICALS IN | 92,700 | $4.3B | 0.58% | |
| 13 | KRYSKRYSTAL BIOTECH INC | 17,300 | $4.3B | 0.57% | |
| 14 | AURAAura Biosciences, Inc. | 360,483 | $2.0B | 0.26% | |
| 15 | ZNTLZentalis Pharmaceuticals Inc. | 1,323,327 | $1.8B | 0.24% | |
| 16 | PYXSPyxis Oncology, Inc (formerly Apexigen) | 326,810 | $375.0M | 0.05% | |
| 17 | FDMT4D MOLECULAR THERAPEUTICS IN | 44,311 | $332.0M | 0.04% | |
| 18 | NUVB/WSNuvation Bio Inc. | 646,057 | $213.0M | 0.03% | |
| 19 | RZLTREZOLUTE INC | 59,900 | $141.0M | 0.02% |